Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Accretive Health, Inc.    

ACCRETIVE HEALTH, INC.
Mes dernières consult.
Most popular
  Report  
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Accretive Health, Inc. : Accretive Health Reports Inducement Grant under NYSE Rule 303A.08

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/04/2013 | 01:05pm CEST

Accretive Health, Inc. (NYSE: AH) today announced that pursuant to the employment agreement entered into with Stephen Schuckenbrock on April 2, 2013, the company granted to Mr. Schuckenbrock on April 3, 2013 a non-qualified stock option under the New York Stock Exchange inducement grant exception. The inducement grant was approved by the company's Board of Directors on April 1, 2013 and is being made as an inducement material to Mr. Schuckenbrock's acceptance of employment with the company, in accordance with New York Stock Exchange Rule 303A.08. The company previously announced that Mr. Schuckenbrock has been appointed President and Chief Executive Officer and a member of the company's Board of Directors, effective April 3, 2013.

The stock option is for the purchase of 2,903,801 shares of the company's common stock, with an exercise price of $9.56, which was the closing price of the company's common stock reported on the New York Stock Exchange on April 3, 2013. The stock option will vest and become exercisable on a ratable monthly basis over 48 months based on continued service to the company, subject to acceleration in specified circumstances.

Accretive Health is providing the above information regarding Mr. Schuckenbrock's inducement grant in accordance with New York Stock Exchange Rule 303A.08.

About Accretive Health

At Accretive Health, our mission is to help our healthcare clients strengthen their financial stability and deliver better care at a more affordable cost to the communities they serve (increasing healthcare access to all). For more information, visit www.accretivehealth.com.

Accretive Health, Inc.
Investor Relations:
Atif Rahim
Telephone: 312.324.5476
email: [email protected]
or
Media:
Puneet Singh
Telephone: 330.565.6802
email: [email protected]


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ACCRETIVE HEALTH, INC.
04/17R1 RCM INC. (OTCMKTS : ACHI) Files An 8-K Regulation FD Disclosure
AQ
04/17R1 RCM INC. : Regulation FD Disclosure (form 8-K)
AQ
04/03R1 RCM INC. (OTCMKTS : ACHI) Files An 8-K Other Events
AQ
04/03R1 RCM INC. : Other Events (form 8-K)
AQ
03/27R1 Appoints Alex Mandl as Lead Director
AQ
03/27R1 RCM INC. (OTCMKTS : ACHI) Files An 8-K Departure of Directors or Certain Offi..
AQ
03/26R1 RCM INC. : Change in Directors or Principal Officers, Other Events (form 8-K)
AQ
03/26R1 Appoints Alex Mandl as Lead Director
GL
03/21R1 RCM INC. (OTCMKTS : ACHI) Files An 8-K Other Events
AQ
03/20R1 RCM INC. : Other Events (form 8-K)
AQ
More news
Financials ($)
Sales 2018 869 M
EBIT 2018 -40,7 M
Net income 2018 -52,8 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019 57,69
EV / Sales 2018 0,88x
EV / Sales 2019 0,89x
Capitalization 764 M
Chart ACCRETIVE HEALTH, INC.
Duration : Period :
Accretive Health, Inc. Technical Analysis Chart | US00438V1035 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 9,67 $
Spread / Average Target 29%
EPS Revisions
Managers
NameTitle
Joseph Gerard Flanagan President, Chief Executive Officer & Director
Thomas A. Lesica Chief Operating Officer & Executive Vice President
Christopher Simon Ricaurte Chief Financial Officer & Treasurer
Alexander J. Mandl Lead Independent Director
Charles J. Ditkoff Independent Director
Sector and Competitors